Extending clinical study will complement the ongoing trial in BulgariaReaffirms it expects to complete the study in 3Q-22 subject to…
Company highlights recent achievements and strategic initiatives setting the foundation to drive revenue growth to record levels in calendar 2022National…
Click here to register for webcastCompany plans to file its Earnings Report on May 10, 2022 on Form 10-Q for…
VANCOUVER, BC / ACCESSWIRE / May 5, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to…
FORT LAUDERDALE, FL / ACCESSWIRE / May 5, 2022 / MediXall Group Inc. (OTCQB:MDXL) ("MediXall"), an innovative healthcare solutions provider,…
RALEIGH, NC / ACCESSWIRE / May 5, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments…
LONDON, UK / ACCESSWIRE / May 5, 2022 / Apollon Formularies plc (AQSE:APOL) ("Apollon" or the "Company"), a UK based…
The IND application for this pilot trial to evaluate oral growth hormone secretagogue, LUM-201, in NAFLD has been approved by…
- $209.7 Million Cash and Cash Equivalents at March 31, 2022 – - Over 120 Patients Now Enrolled in Phase…
Point-of-care cardiac screening solution honored at sixth annual awards program for improving detection of heart disease Eko MedTech Breakthrough Award…